Abstract
The aim of this study was to evaluate the effect of hydroxychloroquine (HCQ) on blood sugar level, lipid profile and retina in newly diagnosed systemic lupus erythromatosus (SLE) patients. Fifty newly diagnosed SLE patients were collected from Immunology and Rheumatology outpatient clinics in Beni Suef University hospital. All patient's questionnaire included name, age, sex, smoking status, the date of the diagnosis, drugs taken during the follow up period and present history of other diseases. Only HCQ was prescribed to the patients within one year follow-up. They were with a mean (SD, range) age 30 (7.07, 25, 35) years old. Their total lipid profile which included total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL), high density lipoprotein (HDL) and fasting blood sugar (FBG) and postprandial blood glucose levels (PPBG) were analyzed in MASTER LAB in Beni suef before and after 6 months from the using of HCQ as well as our patients were converted to Ophthalmology Department in Beni Suef University hospital before and at the end of six months of HCQ therapy to undergo to complete eye examinations. The mean (SD) of TC, TG, LDL, FBG and PPBG were significantly decreased after HCQ than before using it while HDL was increased at p
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
